Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 03 Sept 2026 for REGENXBIO Inc., €39k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Mitchell Chan: trading record in brief
Mitchell Chan discloses dealings in 3 companies, chiefly REGENXBIO Inc., Avalo Therapeutics, Inc. and Viela Bio, Inc. Between 13 March 2021 and 1 September 2026, the trades on record add up to 7 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 3 September 2026 came the latest disclosure, a share grant for €39k in REGENXBIO Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mitchell Chan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
4,902 shares@ US$9.32Common StockSEC:0001789335-26-000008:0
3,166 sharesCommon StockSEC:0001789335-26-000004:0
73,749 shares0Common StockSEC:0001789335-26-000002:0
4,901 shares@ US$8.93100.0% of flowCommon StockSEC:0001562180-25-006078:0
3,167 sharesCommon StockSEC:0001578563-25-000204:0
58,869 shares0Common StockSEC:0001562180-24-006869:0
6 of 6 declarations
